Lisa Patti Diaz
About Lisa Patti Diaz
Lisa Patti Diaz is the Principal Scientist of Biomarker Technologies at Bristol-Myers Squibb, specializing in clinical flow cytometry biomarker assays for clinical trials.
Principal Scientist Biomarker Technologies at Bristol-Myers Squibb
Lisa Patti Diaz currently holds the position of Principal Scientist in Biomarker Technologies at Bristol-Myers Squibb. She is responsible for developing and validating clinical flow cytometry biomarker assays specifically for clinical trials. Her role also involves managing and overseeing the transfer and outsourcing of these assays, ensuring that the processes align with the objectives of clinical studies.
Senior Medical Technologist at Thomas Jefferson University
Lisa Patti Diaz worked as a Senior Medical Technologist at Thomas Jefferson University from 1989 to 1998. In this role, she was responsible for performing and overseeing various medical laboratory tests and ensuring the accuracy and reliability of test results. Her tenure lasted nine years, during which she honed her expertise in medical technology.
Medical Technologist at Penn Medicine
Lisa Patti Diaz worked as a Medical Technologist at Penn Medicine (University of Pennsylvania Health System) from 1985 to 1989. During her four-year tenure, she gained valuable experience in performing laboratory tests and procedures critical to patient care. Her responsibilities also included maintaining and calibrating laboratory equipment to ensure precise and accurate test results.
Education at University of the Sciences in Philadelphia
Lisa Patti Diaz studied at the University of the Sciences in Philadelphia, where she achieved degrees in Clinical Laboratory Science/Medical Technology and a BS in Medical Technology. Her academic background provided her with a solid foundation in laboratory sciences, preparing her for her career in the development and management of clinical assays.
Expertise in Biomarker Assay Development and Validation
Lisa Patti Diaz specializes in the development and validation of clinical flow cytometry biomarker assays. Her expertise includes consulting on clinical sample collection, handling, and processing techniques for cell-based biomarker assays. Additionally, she coordinates the transfer of result data to statistical databases, ensuring the integrity and accuracy of the data used in clinical trials.